Trial intelligence / Profile preview

Antibiotic prophylaxis in pediatric supracondylar humerus fractures

NCT04288206Unknown

Sponsor
Legacy Health
Start
Jan 2021
Primary completion
Oct 2023
Modality
Reversible Covalent Inhibitors
Countries
1
01

Overview

Randomised, double-blind trial in surgical site infection (SSI) comparing Placebo control with Cefazolin prophylaxis (2 arms). Primary endpoints: Deep post operative infection at 3 months and Superficial post operative infection at 3 months. Status: unknown.

02

Drugs

cefazolin
03

Conditions

surgical site infection (SSI)

Beyond the preview

Go deeper on NCT04288206.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04288206.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call